ELIZA SHINALL, FNP-C
Family Nurse Practitioner · SAVANNAH, GA
Individual Active NPI 1376025221
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 359 | 110,863 | $13,562,876 | $4,508,123 | $3,586,791 |
| 2023 | 282 | 92,007 | $10,921,604 | $3,973,044 | $3,156,071 |
| 2022 | 250 | 76,301 | $9,080,108 | $3,002,864 | $2,389,503 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 15,960 | $11 | $9 |
| J1306 | Injection, inclisiran, 1 mg | 13,632 | $12 | $10 |
| J2182 | Injection, mepolizumab, 1 mg | 8,500 | $30 | $24 |
| J0897 | Injection, denosumab, 1 mg | 7,920 | $25 | $20 |
| J3245 | Injection, tildrakizumab, 1 mg | 7,300 | $135 | $107 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 5,100 | $22 | $17 |
| J2357 | Injection, omalizumab, 5 mg | 4,860 | $38 | $30 |
| J9312 | Injection, rituximab, 10 mg | 3,410 | $77 | $61 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,410 | $30 | $24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 587 | $0 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 584 | $11 | $9 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 210 | $46 | $36 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | RN238778 | GA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Georgia
- NPI 1578947529
- NPI 1649714981
- NPI 1821660051
- NPI 1245656321
- NPI 1740679273
- NPI 1881291151
- NPI 1578048872
- NPI 1619565421
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.